Zobrazeno 1 - 7
of 7
pro vyhledávání: '"BUZDAR, A"'
Autor:
Florentia Peintinger, Aman U. Buzdar, Funda Meric-Bernstam, Henry Mark Kuerer, Marjorie C. Green, Judy C. Boughey, Keith Anderson, Gary J. Whitman, S. Eva Singletary, Tanya W. Stephens, W. Fraser Symmans, Kelly K. Hunt
Publikováno v:
Annals of Surgical Oncology. 13:1443-1449
Residual tumor size after neoadjuvant chemotherapy is an important consideration in surgical planning. We examined the accuracy of the combination of mammography and sonography in predicting pathologic residual tumor size. Tumor size was evaluated by
Autor:
Merrick I. Ross, Bruno D. Fornage, S. Eva Singletary, Lisa A. Newman, Fred C. Ames, Kelly K. Hunt, Barry W. Feig, Kapil Dhingra, Gabriel N. Hortobagyi, Aman U. Buzdar, Henry Mark Kuerer
Publikováno v:
Annals of Surgical Oncology. 5:673-680
Background: Induction chemotherapy has become the standard of care for patients with locally advanced breast cancer (LABC) and currently is being evaluated in prospective clinical trials in patients with earlier-stage disease. To better gauge the rol
Autor:
Thomas A. Buchholz, S. Eva Singletary, Lisa A. Newman, Kelly K. Hunt, Frederick C. Ames, Merrick I. Ross, Aman U. Buzdar, Henry Mark Kuerer
Publikováno v:
Annals of surgical oncology. 9(3)
The role of preoperative chemotherapy for breast cancer is evolving. We initiated a prospective trial of sequential preoperative paclitaxel and doxorubicin-based combination chemotherapy in patients with stage I (tumor>1 cm), II, or IIIA disease and
Autor:
Funda Meric, Thomas A. Buchholz, S. Eva Singletary, Lisa A. Newman, Aman U. Buzdar, Fred C. Ames, Barry W. Feig, Nadeem Q. Mirza, Gabriel N. Hortobagyi, Merrick I. Ross, Eric A. Strom, Raphael E. Pollock, Marsha D. McNeese, Kelly K. Hunt
Publikováno v:
Annals of surgical oncology. 7(6)
Although preoperative chemotherapy has become the standard of care for inoperable locally advanced breast cancer, its role for downstaging resectable primary tumors is still evolving. The purpose of this study was to determine whether the prognostic
Publikováno v:
Annals of surgical oncology. 3(2)
Background: To determine if aggressive treatment of locoregional recurrence affects survival, we retrospectively analyzed the clinical outcome of 69 breast cancer patients who developed locoregional disease as their first episode of recurrence follow
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.